Compounds > alpha-methyltyrosine methyl ester
Page last updated: 2024-10-22

alpha-methyltyrosine methyl ester and Hyperprolactinemia

alpha-methyltyrosine methyl ester has been researched along with Hyperprolactinemia in 1 studies

alpha-methyltyrosine methyl ester: RN given refers to parent cpd

Hyperprolactinemia: Increased levels of PROLACTIN in the BLOOD, which may be associated with AMENORRHEA and GALACTORRHEA. Relatively common etiologies include PROLACTINOMA, medication effect, KIDNEY FAILURE, granulomatous diseases of the PITUITARY GLAND, and disorders which interfere with the hypothalamic inhibition of prolactin release. Ectopic (non-pituitary) production of prolactin may also occur. (From Joynt, Clinical Neurology, 1992, Ch36, pp77-8)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Rung, JP1
Rung, E1
Johansson, AM1
Svensson, K1
Carlsson, A1
Carlsson, ML1

Other Studies

1 other study available for alpha-methyltyrosine methyl ester and Hyperprolactinemia

ArticleYear
Effects of the dopamine stabilizers (S)-(-)-OSU6162 and ACR16 on prolactin secretion in drug-naive and monoamine-depleted rats.
    Naunyn-Schmiedeberg's archives of pharmacology, 2011, Volume: 384, Issue:1

    Topics: Animals; Aripiprazole; Dopamine; Dopamine Agonists; Dopamine Antagonists; Dopamine D2 Receptor Antag

2011